Relapse rate is significantly lower in the patients with LONIPCs
. | Total no. of relapses . | Relapses in non-LONIPCs . | Relapses in LONIPCs . | P . |
|---|---|---|---|---|
| No. of patients | 17 of 69 | 16 of 52 | 1 of 17 | .0387 |
| Chronic GVHD | 11 of 46 | 10 of 31 | 1 of 15 | .0565 |
| Extensive-type chronic | ||||
| GVHD | 9 of 36 | 8 of 22 | 1 of 14 | .0484 |
. | Total no. of relapses . | Relapses in non-LONIPCs . | Relapses in LONIPCs . | P . |
|---|---|---|---|---|
| No. of patients | 17 of 69 | 16 of 52 | 1 of 17 | .0387 |
| Chronic GVHD | 11 of 46 | 10 of 31 | 1 of 15 | .0565 |
| Extensive-type chronic | ||||
| GVHD | 9 of 36 | 8 of 22 | 1 of 14 | .0484 |